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A B S T R A C T
Background
Age-related cataract is a major cause of blindness and visual morbidity worldwide. It is therefore important to establish the optimal
technique of lens removal in cataract surgery.
Objectives
To compare manual small incision cataract surgery (MSICS) and phacoemulsification techniques.
Search methods
We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (The Cochrane Library 2013, Issue 6),
Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE
(January 1946 to July 2013), EMBASE (January 1980 to July 2013), Latin American and Caribbean Literature on Health Sciences
(LILACS) (January 1982 to July 2013), Web of Science Conference Proceedings Citation Index - Science (CPCI-S) (January 1970
to July 2013), the metaRegister of Controlled Trials (mRCT) (www.controlled-trials.com), ClinicalTrials.gov (www.clinicaltrials.gov)
and the WHO International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We did not use any date or
language restrictions in the electronic searches for trials. We last searched the electronic databases on 23 July 2013.
Selection criteria
We included randomised controlled trials (RCTs) for age-related cataract that compared MSICS and phacoemulsification.
Data collection and analysis
Two authors independently assessed all studies. We defined two primary outcomes: ’good functional vision’ (presenting visual acuity of
6/12 or better) and ’poor visual outcome’ (best corrected visual acuity of less than 6/60). We collected data on these outcomes at three
and 12 months after surgery. Complications such as posterior capsule rupture rates and other intra- and postoperative complications
were also assessed. In addition, we examined cost effectiveness of the two techniques. Where appropriate, we pooled data using a
random-effects model.
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Main results
We included eight trials in this review with a total of 1708 participants. Trials were conducted in India, Nepal and South Africa. Follow-
up ranged from one day to six months, but most trials reported at six to eight weeks after surgery. Overall the trials were judged to be
at risk of bias due to unclear reporting of masking and follow-up. No studies reported presenting visual acuity so data were collected
on both best-corrected (BCVA) and uncorrected (UCVA) visual acuity. Most studies reported visual acuity of 6/18 or better (rather
than 6/12 or better) so this was used as an indicator of good functional vision. Seven studies (1223 participants) reported BCVA of
6/18 or better at six to eight weeks (pooled risk ratio (RR) 0.99 95% confidence interval (CI) 0.98 to 1.01) indicating no difference
between the MSICS and phacoemulsification groups. Three studies (767 participants) reported UCVA of 6/18 or better at six to eight
weeks, with a pooled RR indicating a more favourable outcome with phacoemulsification (0.90, 95% CI 0.84 to 0.96). One trial (96
participants) reported UCVA at six months with a RR of 1.07 (95% CI 0.91 to 1.26).
Regarding BCVA of less than 6/60: there were only 11/1223 events reported. The pooled Peto odds ratio was 2.48 indicating a more
favourable outcome using phacoemulsification but with wide confidence intervals (0.74 to 8.28) which means that we are uncertain as
to the true effect.
The number of complications reported were also low for both techniques. Again this means the review is underpowered to detect a
difference between the two techniques with respect to these complications. One study reported on cost which was more than four times
higher using phacoemulsification than MSICS.
Authors’ conclusions
On the basis of this review, removing cataract by phacoemulsification may result in better UCVA in the short term (up to three months
after surgery) compared to MSICS, but similar BCVA. There is a lack of data on long-term visual outcome. The review is currently
underpowered to detect differences for rarer outcomes, including poor visual outcome. In view of the lower cost of MSICS, this may be
a favourable technique in the patient populations examined in these studies, where high volume surgery is a priority. Further studies are
required with longer-term follow-up to better assess visual outcomes and complications which may develop over time such as posterior
capsule opacification.
P L A I N L A N G U A G E S U M M A R Y
Comparing two different techniques of removing cataracts
Cataract is a clouding of the lens in the eye, which most commonly occurs due to increasing age. This can only be treated with an
operation, and the aim of this review was to assess two different surgical methods. The first, called manual small incision cataract
surgery (MSICS) involves using instruments to remove the lens from the eye through a small incision. The second, phacoemulsification,
involves using a high frequency ultrasound probe to fragment the lens, and this machine also removes the lens fragments from the eye.
We searched the literature in July 2013 and identified eight randomised controlled trials that compared these two techniques. These
included a total of 1708 participants randomly allocated to MSICS or phacoemulsification. The studies were carried out in India,
Nepal and South Africa.
Not all studies reported the outcomes of visual acuity that we aimed to assess, making it difficult to draw definite conclusions. Better
uncorrected visual acuity was seen in the short term with phacoemulsification; however, there were no differences in best-corrected
visual acuity (i.e. after correction with spectacles). There appeared to be no significant difference regarding uncorrected visual acuity
between the two techniques at six months in the one trial that reported at that time point. There was a lack of long-term data (one year
or more after surgery). Very few participants were reported to have poor visual outcomes or complications (such as posterior capsule
rupture) from the surgery. The cost of phacoemulsification was documented in one study only, and this was more than four times the
cost of MSICS.
In this setting, the two techniques appear to be comparable in terms of visual acuity outcomes and complications. However further
studies with a longer follow-up period are needed to better assess these outcomes.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Manual small incision cataract surgery (MSICS) compared with phacoemulsification for age-related cataract
Patient or population: people with age-related cataract
Settings: hospital
Intervention: manual small incision surgery
Comparison: phacoemulsification
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Phacoemulsification MSICS
Good functional vision
(presenting visual acu-
ity 6/12 or better) 12
months after surgery
See comment No study reported pre-
senting visual acuity; few
studies reported 6/12 out-
comes; only one study re-
ported at 12 months
Seven studies reported
best-corrected visual acu-
ity (BCVA) of 6/18 or better
at threemonths (pooled RR
0.99 (95% CI 0.98 to 1.01)
) and three studies reported
uncorrected visual acuity
(UCVA) of 6/18 or better at
three months (pooled RR
in favour of phacoemulsifi-
cation 0.90 (95% CI 0.84
to 0.96)
Poor visual outcome
(best-corrected visual
acuity worse than 6/60)
12 months after surgery
1 per 10001 2 per 1000
(1 to 8)
OR: 2.48 (95% CI 0.74 to
8.28)
1250
(6)
⊕©©©
very low2,3,4
No data available at 12
months so data from three
months follow-up used
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Posterior capsule opaci-
fication 12 months after
surgery
See comments 494
(2)
⊕©©©
very low4,5,6
Posterior capsule opacifi-
cation was reported in two
studies. At six weeks no
cases were observed in
Gogate 2005a and at six
months 20/46 MSICS ver-
sus 7/48 phacoemulsifica-
tion cases were observed
inRuit 2007 (OR2.98, 95%
CI 1.39 to 6.37).
Other complications See comments No data on retinal detach-
ment, glaucoma, cystoid
macular oedemaor corneal
decompensation
Quality of life See comments No data reported
Costs See comments In the Ruit 2007 study,
phacoemulsification cost
USD 70 per case and
MSICS cost USD 15 per
case
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk Ratio; OR: Odds Ratio
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1 Risk in phacoemulsification group ranged from 0 per 1000 to 25 per 1000 in the included studies; the median risk was 0. We have
therefore estimated a low risk in the phacoemulsification group at 1 per 1000.
2 Downgraded for risk of bias: several items on risk of bias assessment not clearly reported.
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3 Downgraded for imprecision: wide confidence intervals.
4 Downgraded for indirectness (not measured at 12 months).
5 Downgraded for inconsistency: only one study reported so not possible to assess.
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B A C K G R O U N D
Description of the condition
Cataract is the opacification of the normally transparent lens of
the eye and occurs as a result of denaturation of lens proteins. This
cloudiness can cause a decrease in vision and may lead to eventual
blindness. Most cataracts are age-related. The density and location
of the cataract determines the amount of vision affected. Initially,
cataracts may not affect vision and if the cataract remains small
or at the periphery of the lens, the visual changes may be minor.
If the cataract forms in the area of the lens directly behind the
pupil, vision may be significantly impaired. It is not thought to be
reversible and surgery is currently the only treatment option. In the
months or years after cataract surgery a small percentage of people
will develop a condition called posterior capsular thickeningwhich
can be treated. A laser treatment, YAG laser capsulotomy, makes
a small opening in the back of the lens capsule, which restores
vision.
TheWorld Health Organization (WHO) estimated from a recent
global review of surveys that there are 37million people worldwide
who were blind in 2002 (Passolini 2004; Resnikoff 2004) and
that age-related cataract remained the leading cause of blindness
globally in 2002, as it was in 1990. Fifty per cent of total world
blindness is thought to be due to cataract, with the majority of
blinding cataract found in developing countries. The contribution
of cataracts to blindness globally is likely to grow due to an age-
ing population and unsuccessful attempts to control this blinding
condition in low- and middle-income countries (WHO 2005).
Description of the intervention
Phacoemulsification was first described in 1967 by Charles D.
Kelman, an American ophthalmologist (1930 to 2004). It is the
most commonly performed method of cataract extraction in the
developedworld and involves ultrasonic fragmentation of the crys-
talline lens. The incision is small (with a standard size of around
2.75 mm, but may range from 2.2 mm to 3.2 mm) which allows
rapid visual rehabilitation postoperatively and low induced astig-
matism. This technique requires a phacoemulsification machine
which may cost GBP 20,000 to GBP 45,000 and has high dis-
posable and maintenance costs. Phacoemulsification requires ex-
tensive surgical training, particularly the necessity to carry out a
continuous capsulorhexis.
Manual small incision cataract surgery (MSICS)was first described
by Blumenthal 1992. In Asia and Africa there has been a re-
newal of interest in this technique (Ruit 2000) as an alternative to
phacoemulsification, because it is considerably less costly but has
similar benefits of rapid visual recovery and reduced astigmatism
(Yorston 2005). It involves a 6 mm to 6.5 mm scleral incision,
just large enough to allow insertion of a 6 mm intraocular lens
(IOL). There are various different techniques described for per-
forming the capsulotomy in MSICS, for example, the can-opener
method (Gogate 2005b), the continuous curvilinear capsulorhexis
(Gogate 2003) and the endocapsular technique where the incision
is from pupil margin to pupil margin. The lens is delivered into
the anterior chamber, hydroextracted and aspirated. The posterior
capsule of the lens is left intact. This technique is technically more
difficult than a standard manual extracapsular extraction (ECCE).
Figure 1 summarises the different types of cataract surgery.
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Figure 1. Types of cataract surgery
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How the intervention might work
Cataract surgery consists of removing the lens of the eye and re-
placing it with an artificial lens called an intraocular lens. IOLs
can be made from a range of materials, and can be of varying
size, shape and refracting power. Before cataract surgery the eye to
be operated on is measured so that an IOL of the correct power
(strength) can be inserted after the cataract has been removed. The
IOL is usually placed inside the ’bag’ of the lens capsule inside the
eye. Other options for lens replacement include contact lenses and
cataract glasses.
Why it is important to do this review
Although phacoemulsification is the most technologically ad-
vanced method providing small-incision, sutureless surgery it re-
quires considerable resources in the form of the initial capital out-
lay for the phacoemulsification machine, and there are consider-
able ongoing costs due to consumables, maintenance and training
of surgeons. It is the procedure of choice for cataract surgery in
high-income countries.
From a global perspective phacoemulsification is too costly for
many developing countries where there is the highest incidence
of cataract blindness. Manual small incision cataract surgery and
ECCE are alternative techniques available at a lower cost. A key
question is whether the resources required for phacoemulsification
are justified in a lower-income setting.
This review in its original form ‘Surgical interventions for age-
related cataract’ (Riaz 2006) compared the outcomes of different
cataract surgical techniques. The techniques included initiallywere
intracapsular extraction (ICCE), ECCE and phacoemulsification.
In 2006 it was revised and a fourth surgical technique, MSICS,
was added to the review.
Following consultation with the authors and the Cochrane Eyes
and Vision Group this update has been divided into three smaller
reviews each using the same outcomemeasures but only comparing
two surgical methods within each review. The ICCE technique is
no longer included as this method is no longer used as a primary
procedure.
The cataract surgical techniques compared in these three reviews
are:
1. MSICS and ECCE (Ang 2012);
2. Phacoemulsification and ECCE (Riaz 2010a);
3.MSICS andphacoemulsification (current review, publishedpro-
tocol Riaz 2010b).
O B J E C T I V E S
The aim of this review is to compare the effects of two types of
cataract surgery: manual small incision cataract surgery (MSICS)
and phacoemulsification.
Our secondary objective is to compare the costs of the two proce-
dures as reported in included trials.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We include randomised controlled trials (RCTs) only in this re-
view.
Types of participants
We include trials where participants were people with age-related
cataract.
Types of interventions
We include trials that comparedMSICSwith phacoemulsification,
followed by implantation of a posterior chamber intraocular lens
(IOL) in both techniques.
Types of outcome measures
Primary outcomes
Postoperative visual acuity
• proportion of people achieving good functional vision,
defined as presenting* visual acuity better than or equal to 6/12
in the operated eye.
• proportion of people with a poor outcome after surgery,
defined as best-corrected visual acuity (BCVA) worse than 6/60
in the operated eye.
* ’Presenting visual acuity’ is vision that the person uses in normal
life, i.e. with or without glasses, if worn.
Secondary outcomes
• Intraoperative complications
◦ capsular rupture with or without vitreous loss
◦ iris prolapse
◦ postoperative inflammation
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◦ other complications as reported
• Long-term complications (one year or more after surgery)
◦ posterior capsule opacification
◦ retinal detachment
◦ glaucoma
◦ cystoid macular oedema
◦ corneal endothelial cell loss
◦ corneal decompensation
◦ other complications as recorded
• Quality of life (self care, mobility, social and mental
function) as reported
• Cost effectiveness
Follow-up
Outcomes were measured at three months and one year after
surgery. As studies may not report outcomes exactly at these time
points, data collection was considered within the following time
periods:
• three months: from four weeks to less than six months
• 12 months: from six months to less than 18 months
Search methods for identification of studies
Electronic searches
We searched the Cochrane Central Register of Controlled Tri-
als (CENTRAL) 2013, Issue 6, part of The Cochrane Li-
brary. www.thecochranelibrary.com (accessed 23 July 2013), Ovid
MEDLINE, Ovid MEDLINE In-Process and Other Non-In-
dexed Citations, Ovid MEDLINE Daily, Ovid OLDMED-
LINE (January 1946 to July 2013), EMBASE (January 1980
to July 2013), Latin American and Caribbean Health Sci-
ences (LILACS) (January 1982 to July 2013), Web of Sci-
ence Conference Proceedings Citation Index - Science (CPCI-
S) (January 1970 to July 2013), the metaRegister of Controlled
Trials (mRCT) (www.controlled-trials.com), ClinicalTrials.gov (
www.clinicaltrials.gov) and theWHOInternational Clinical Trials
Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We
did not use any date or language restrictions in the electronic
searches for trials. We last searched the electronic databases on 23
July 2013.
See: Appendices for details of search strategies for CENTRAL
(Appendix 1),MEDLINE (Appendix 2), EMBASE (Appendix 3),
LILACS (Appendix 4), CPCI-S (Appendix 5), mRCT (Appendix
6), ClinicalTrials.gov (Appendix 7) and the ICTRP (Appendix 8).
Searching other resources
We searched the reference lists of identified included studies. We
contacted study authors and other experts in the field to identify
unpublished studies or studies sent for publication or in press.
Data collection and analysis
Selection of studies
Two review authors independently screened the titles and abstracts
resulting from the electronic searches. Duplicate records were re-
moved, as were obviously irrelevant titles and abstracts. We ob-
tained full-text copies of any report referring to definitely or possi-
bly relevant trials. Multiple reports of the same study were linked
together.We assessed these full-text reports for compliance of stud-
ies with eligibility criteria, and then assessed trials that met these
criteria for methodological quality.
All studies that were excluded at this stage were documented and
reasons for exclusion provided.
Data extraction and management
We extracted data using a form developed by the Cochrane Eyes
and Vision Group. Two authors extracted data and compared the
results for differences. We resolved discrepancies by discussion.
Any disagreements which could not be resolved were initially ad-
dressed by contacting the study authors, and if this was unsuccess-
ful were reported in the review. Data were entered onto a spread-
sheet, checked for accuracy by all review authors, and then cut and
pasted into Review Manager 5 (RevMan 2012).
Assessment of risk of bias in included studies
We assessed the risk of bias in each study using The Cochrane Col-
laboration’s tool for assessing the risk of bias as detailed in Chap-
ter 8 of the Cochrane Handbook for Systematic Reviews of inter-
ventions (Higgins 2011).We considered the following parameters:
sequence generation, allocation sequence concealment, masking
(blinding), incomplete outcome data, selective outcome report-
ing and other potential sources of bias. We judged whether they
were at high risk of bias, low risk of bias or unclear. Two review
authors independently assessed the risk of bias and disagreement
was resolved by discussion. Authors were not masked to the report
authors and trial results during the assessment.
Measures of treatment effect
The outcomes for this review were largely dichotomous (i.e. post-
operative visual acuity and complications). Our measure of treat-
ment effect was the risk ratio. For outcomes that occurred rarely
(in less than 10% of the cohort), we used the Peto odds ratio.
Corneal endothelial cell loss was reported as a continuous variable
and was analysed using the mean difference. Currently the review
does not include data on quality of life. In future updates this may
become available. It may be reported as a continuous variable, in
which case the mean difference will be used.
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Unit of analysis issues
In all studies included in this review, data were reported for one
eye per person, although it was not always clear how the study eye
was selected.
Dealing with missing data
We collected information on follow-up by treatment groups, and
the reasons formissing data, although this was not always reported.
The analyses in this review are based on available data and there-
fore assume that missing data are missing at random. We origi-
nally planned to investigate how reasonable this assumption is by
doing a series of sensitivity analyses with different assumptions
about the missing data using methods as set out by White 2008.
However, data currently included in the review are sparse and we
have therefore not done these sensitivity analyses for this initial
version of the review.
Assessment of heterogeneity
We assessed heterogeneity in several ways. Firstly, by documenting
clinical and methodological differences between the studies. Sec-
ondly by examining the forest plots to see whether the estimates
of effect are consistent, and thirdly by considering the I² value and
Chi² test for heterogeneity (bearing in mind that the Chi² test has
low power when the number of trials is small) (Higgins 2003).
Assessment of reporting biases
The main reporting biases that we planned to consider were pub-
lication bias and outcome reporting bias. Currently there are not
enough trials included in the review to assess publication bias. In
order to assess the possibility of outcome reporting bias we did a
review outcome matrix using the ORBIT classification (Kirkham
2010).
Data synthesis
Where data were available, we pooled the results using a random-
effects model if there were more than three studies, and a fixed-ef-
fect model if there were three or fewer studies. For data on compli-
cations, as the number of events was small, we used the Peto odds
ratio (fixed-effect model). As a general rule, if there was substantial
heterogeneity as defined above (Assessment of heterogeneity), we
planned not to report a pooled estimate, depending on the size of
studies and consistency of the effect estimates.
Subgroup analysis and investigation of heterogeneity
We did not plan or conduct any subgroup analyses.
Sensitivity analysis
We planned to do a sensitivity analysis excluding trials at high risk
of bias and investigating the impact of missing data (see Dealing
with missing data). However, currently there are not enough data
to enable this.
Summary of findings table
We prepared a ’Summary of findings’ table and assessed the qual-
ity of the body of evidence for each outcome using the GRADE
approach as described in Chapter 12 of the Cochrane Handbook
for Systematic Reviews of interventions (Schünemann 2011). This
was done by one author (JE) and checked by the other authors.
R E S U L T S
Description of studies
Results of the search
The electronic searches yielded a total of 748 records (Figure
2). After deduplication we screened the title and abstract of 541
records. We excluded 523 records as not relevant to the scope of
the review. We obtained full-text copies of 17 records for further
investigation. We excluded eight studies, see Characteristics of
excluded studies and included eight studies (nine reports) see
Characteristics of included studies.
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Figure 2. Results from searching for studies for inclusion in the review.
11Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus phacoemulsification with posterior
chamber intraocular lens for age-related cataract (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Included studies
We included eight randomised controlled trials (RCTs) for analy-
sis in this review (Cook 2012; George 2005; Ghosh 2010; Gogate
2005a; Gogate 2010; Ruit 2007; Singh 2009; Venkatesh 2010).
See Characteristics of included studies for further details. All stud-
ies comparedmanual small incision cataract surgery (MSICS)with
phacoemulsification. One trial had an additional extracapsular ex-
traction (ECCE) arm (George 2005).
Participants:A total of 1708peoplewere included in these studies:
200 (Cook 2012); 124 (George 2005); 224 (Ghosh 2010); 400
(Gogate 2005a); 200 (Gogate 2010); 108 (Ruit 2007); 182 (Singh
2009); 270 (Venkatesh 2010).
Demographics: The average age of participants ranged from 56
to 68. Approximately equal numbers of women and men were
enrolled (range percentage of women from 44.2% to 61%).
Location: Five of the included studies were conducted in In-
dia (George 2005; Ghosh 2010; Gogate 2005a; Gogate 2010;
Venkatesh 2010), two in Nepal (Ruit 2007; Singh 2009) and one
in South Africa (Cook 2012).
Outcomes: All eight studies evaluated Snellen visual acuity out-
comes. Six studies reported visual acuity as their main outcome
whereas George 2005 reported endothelial cell loss and surgery-
induced astigmatism as their main outcome, and Ghosh 2010 re-
ported macular thickness as the primary outcome. Postoperative
complications were recorded in all studies.
Follow-up: Singh 2009 reported results on the first postopera-
tive day only; George 2005; Gogate 2005a; Gogate 2010 and
Venkatesh 2010 reported results at six weeks, Cook 2012 reported
results at eight weeks; Ghosh 2010 and Ruit 2007 reported data
up to six months postoperatively.
Excluded studies
See Characteristics of excluded studies table.
Risk of bias in included studies
Risk of bias is summarised in Figure 3 and Figure 4. See individual
’Risk of bias’ tables for more detailed information on each study.
Figure 3. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 4. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
All eight trials clearly stated how participants were allocated to
each arm of the study. Five trials described using picking a ball
or ‘ballots’ for assignment of treatment and surgeon (Cook 2012;
Ghosh 2010; Gogate 2005a; Gogate 2010; Ruit 2007). Two stud-
ies used computer-generated random numbers (George 2005;
Venkatesh 2010) and another study used a random number ta-
ble (Singh 2009). Allocation concealment was described in five
studies (Cook 2012; Ghosh 2010; Gogate 2005a; Gogate 2010;
Venkatesh 2010).
Blinding
Performance bias
Five studies (Cook 2012; Ghosh 2010; Gogate 2005a; Gogate
2010; Venkatesh 2010) reported masking of participants to the
nature of surgery.
Detection bias
Four studies reported that masking was carried out and that post-
operative assessors were masked to the nature of surgery (Cook
2012; Ruit 2007; Singh 2009; Venkatesh 2010). However, ob-
vious differences in postoperative appearance of the eye in each
group may influence the ability to mask assessors.
Incomplete outcome data
Follow-up rates were variable between the included studies: 82.5%
(Cook 2012); 91% (George 2005); 86% (Ghosh 2010); 93%
(Gogate 2005a); 73% (Gogate 2010); 87% (Ruit 2007);100%
(Singh 2009); 85% (Venkatesh 2010) respectively. Only Cook
2012 stated the reason for attrition, which was the distance needed
to travel by participants living in rural areas.
Selective reporting
The only intraoperative complication described in George 2005
was posterior capsular rupture. Otherwise, a range of outcomes
were reported in all other studies. Without access to the protocols
for the studies it was difficult to assess this bias formally. However,
we compiled an ’outcome reporting matrix’ (Table 1) using the
ORBIT classification (Kirkham 2010). We did not identify any
cause for concern.
Other potential sources of bias
The level of surgical experience for each technique performedmay
be a source of bias. However, this would only be the case if there
were imbalance between study groups in level of experience of the
surgeon. In Cook 2012, 35% of phacoemulsification surgeries and
58% of MSICS surgeries were done by a team of five consultants.
The remainder of surgery was done by 10 registrars, who were
reported to be competent in the technique but had varying levels
of experience. If the assumption is made that consultants were
more experienced, this may be a potential source of bias in favour
of MSICS outcomes.
In George 2005; Gogate 2005a; Ruit 2007 and Venkatesh 2010,
all surgeons had comparable levels of experience. In Singh 2009
there was only one surgeon and it is not stated whether he had
equal surgical experience of both techniques. In Ghosh 2010 there
were two surgeons who performed equal amounts of surgery. In
Gogate 2010 neither the number of surgeons nor the level of
surgical experience is stated.
Effects of interventions
See: Summary of findings for the main comparison
Primary outcomes
Visual outcomes
Good functional vision
We defined ’good functional vision’ as presenting visual acuity of
6/12 or better. No studies reported presenting visual acuity so we
report both uncorrected (UCVA) and best-corrected visual acuity
(BCVA). Most studies reported outcomes of 6/18 or better, rather
than 6/12 or better, so this outcome has been used as an indicator
of good functional vision.
Uncorrected visual acuity (UCVA)
Five studies reported UCVA of 6/18 or better, with one study
reporting this outcome at one day only (Singh 2009), two studies
at six weeks (Gogate 2005a; Venkatesh 2010), one study at eight
weeks (Cook 2012) and one study at six months (Ruit 2007).
At one day postoperatively, UCVA of 6/18 or better was found
in 77.7% of participants in the MSCIS group and 68% of par-
ticipants in the phacoemulsification group (P = 0.0655) (Singh
2009).
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At six weeks, Gogate 2005a reported UCVA of 6/18 or better
in 133/187 (71%) of MSICS participants compared to 150/185
(81%) of phacoemulsification participants (risk ratio (RR) 0.88,
95% confidence interval (CI) 0.78 to 0.98). Venkatesh 2010 re-
ported this outcome in 96/117 (82%) MSICS participants and
99/113 (88%) phacoemulsification participants (RR 0.94, 95%
CI 0.84 to 1.04). At eight weeks, Cook 2012 reported this out-
come in 63/85 (74%) MSICS participants and 69/80 (86%) pha-
coemulsification participants (RR 0.86, 95% CI 0.74 to 1.00).
The pooled RR for this outcome was 0.90, (95% CI 0.84 to 0.96)
which favours phacoemulsification (Analysis 1.1).
At six months, Ruit 2007 reported 41/46 (89%) of the MSICS
group had UCVA of 6/18 or better compared with 40/48 (83%)
of the phacoemulsification group (RR 1.07, 95% CI 0.91 to 1.26)
(Analysis 1.2).
Best-corrected visual acuity (BCVA)
More studies reported BCVA (Analysis 1.3). At three months
there was no difference between MSICS and phacoemulsification
groups (pooled RR 0.99, 95% CI 0.98 to 1.01) (Analysis 1.3).
One trial only reported at six months (Ruit 2007) with a RR of
1.0 (95% CI 0.94 to 1.06) (Analysis 1.4).
Poor visual outcome after surgery
We defined a poor outcome after surgery as BCVA of less than 6/
60.
Six studies reported poor visual outcome data within threemonths
postoperatively, with no cases in either group in three out of six
studies. In total 8/617 MSICS cases and 3/606 phacoemulsifi-
cation cases had BCVA worse than 6/60. With low numbers of
events, the true estimate of effect is uncertain with a pooled Peto
OR of 2.48 in favour of phacoemulsification and wide confidence
intervals (95% CI 0.74 to 8.28; Analysis 1.5).
Ruit 2007 reported 1.9% of cases in both MSICS and pha-
coemulsification groups had BCVAworse than 6/18 at six months
(Analysis 1.6).
Secondary outcomes
Intraoperative surgical complications
Posterior capsule rupture (PCR) was reported in all studies
(Analysis 1.7). Inmost studies few cases of PCRwere reported.The
number of cases reported varied between studies from no events
in either group (George 2005) to 10/100 in the MSICS and 4/
100 in the phacoemulsification group (Cook 2012). Overall there
was little evidence of any difference between the two intervention
groups (Peto OR 1.07, 95% CI 0.63 to 1.83).
Five studies reported iridodialysis (Analysis 1.8). There were too
few cases (seven) to detect any difference between MSICS and
phacoemulsification (Peto OR 2.37, 95% CI 0.54 to 10.45). Two
studies reported zonule dialysis (Gogate 2005a; Singh 2009) but
again the number of cases (three) was low.
Three studies (Gogate 2005a; Gogate 2010; Ruit 2007) reported
extension of capsulorrhexis during surgery (Analysis 1.9). This
appeared to occur more commonly in the phacoemulsification
group, but again the number of cases was low (six); Peto OR 0.26
(95% CI 0.05 to 1.30).
In Gogate 2005a, 2/199 cases allocated to the phacoemulsification
groups were converted to MSICS; in Gogate 2010 this was 5/
100 cases (three due to zonular dialysis and two due to posterior
capsule tears), in Cook 2012 8/100 cases (due to hard nucleus)
and in Venkatesh 2010 3/137 cases.
Postoperative inflammation was reported in three studies (11 cases
in total) (Analysis 1.10). In theRuit 2007 study, no events occurred
in either group.
Postoperative complications
Early postoperative corneal oedema (occurring at day 1 to day 7)
was reported in six studies (Analysis 1.11) with a total of 60/739
cases in the MSICS group and 93/737 cases in the phacoemulsi-
fication group. Overall there appeared to be more cases of early
postoperative corneal oedema in the phacoemulsification group
(Peto OR 0.58, 95% (CI) 0.41 to 0.83). In four studies, no events
of corneal oedema were reported at three to six weeks (Analysis
1.12).
Posterior capsule opacification was reported in two studies (
Analysis 1.13). At six weeks no cases were observed in Gogate
2005a, and at six months 20/46MSICS versus 7/48 phacoemulsi-
fication cases were observed in Ruit 2007 (RR 2.98, 95% CI 1.39
to 6.37).
No significant difference between percentage endothelial cell loss
was found between the two techniques (Analysis 1.14). George
2005 reported a 5.41% endothelial cell loss at six weeks in the
phacoemulsification group, and 4.21% in the MSICS group (P
= 0.855). Gogate 2010 reported a mean endothelial cell loss at
one week of 16.1% in the phacoemulsification group, and 12.2%
in the MSICS group (P = 0.06). At six weeks the percentage loss
was 18.4% in the phacoemulsification group, and 17.7% in the
MSICS group (P = 0.44).
Other reported findings
Surgically induced astigmatism (SIA)
This was reported in six studies (George 2005; Ghosh 2010;
Gogate 2005a; Ruit 2007; Singh 2009; Venkatesh 2010).
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At one day postoperatively, Singh 2009 reported a mean induced
astigmatism of 0.11 dioptre (D) (SD 0.74) for the phacoemulsifi-
cation group and 0.09 (SD 0.82) for the MSICs group.
At six to eight weeks postoperatively, three studies reported a
greater SIA in the MSICS groups: George 2005 (mean SIA 1.1
± 0.95 D MSICS versus 0.77 ± 0.65 D phacoemulsification);
Venkatesh 2010 (mean SIA 1.20 ± 0.36 D MSICS versus 0.8
± 0.24 D phacoemulsification) and Cook 2012 (median SIA -
1.50 DMSICS versus -1.00 D phacoemulsification). At this time
point, Gogate 2005a found mean astigmatism was almost equal
in the two groups (1.1 D phacoemulsification group versus 1.2 D
MSICs group). They also found that 47/185 participants in the
phacoemulsification group and 40/187 in the small incision group
had no astigmatism at all.
At six months postoperatively, Ruit 2007 did not show any signif-
icant difference in keratometric astigmatism between the MSICS
group (0.88 D) and the phacoemulsification group (0.70 D) (P =
0.12).
Cost evaluation and surgical time
In Ruit 2007, phacoemulsification cases took 15.5 minutes each
on average (cost USD 70 per case), whereas MSICS cases took
nine minutes per case on average (cost USD 15 per case). Surgical
time was reported in two studies, and was shorter in the MSICS
group in both. Singh 2009 reported surgical time was less than six
minutes in 11.2% of phacoemulsification and 84.9% of MSICS
cases. Venkatesh 2010 reported mean surgical time of 8.8 +/- 3.4
minutes in the MSICS group and 12.2 +/- 4.6 minutes in the
phacoemulsification group.
D I S C U S S I O N
Summary of main results
The results are summarised in Summary of findings for the main
comparison.
We defined a good visual outcome as presenting acuity of 6/12 or
better. Presenting acuity was not reported by any trial and we have
reported both best-corrected (BCVA) and uncorrected (UCVA)
visual acuity. There was some evidence of a better visual outcome
regarding UCVA at six weeks in participants in the phacoemul-
sification group versus the manual small incision cataract surgery
(MSICS) group based on the results of three studies (Cook 2012;
Gogate 2005a; Venkatesh 2010). However, there was no evidence
of any difference in BCVA. Only one trial reported at longer time
periods (six months), and found no difference in either corrected
or uncorrected acuity.
We defined poor visual outcome as BCVA of less than 6/60. There
were a small number of events reported in either group in any
study, so it is uncertain as to whether there are differences between
the two groups with respect to poor visual outcome.
The number of complications reported were also low for both
techniques. Again thismeans the review is currently underpowered
to detect a difference between the two techniques with respect to
these complications. Althoughmost studies did not report postop-
erative corneal oedema, in the two studies that did there was some
evidence that phacoemulsification caused more immediate post-
operative oedema than MSICS. Further investigation is required
to assess whether this effect is dependent on the setting in which
the studies were conducted: for example, levels of cataract severity
and degree of surgical experience may be possible explanations of
this effect
No data were reported on quality of life. The cost of phacoemul-
sification was more than four times greater per case than MSICS
(Ruit 2007).
Overall completeness and applicability of
evidence
The outcomes reported by the included studies differed widely,
making it difficult to collate evidence from all studies. Any con-
clusions must therefore be treated with caution due to the small
numbers involved. The majority of studies were performed in In-
dia and Nepal in high output surgical units, and thus these results
can not easily be applied to other settings, such as in developed
countries. The one study carried out in South Africa concluded
that the outcomes of phacoemulsification were better for UCVA,
BCVA and astigmatism. However, this study involved 15 surgeons
of varying experience, so the results may reflect surgical expertise
rather than surgical technique.
We considered quite a number of secondary outcomes, and it is
possible that some significant findings might have arisen due to
chance. As the number of events was low we did not observe many
statistically significant findings and we think it unlikely that the
overall conclusions of the review are based on chance findings.
Quality of the evidence
Overall we graded the quality of the evidence as low or very low. All
studies included were randomised controlled trials (RCTs). How-
ever, the level of evidence for many outcomes was downgraded due
to lack of data reported in assessing risk of bias, imprecision (wide
confidence intervals) and inconsistency (for example, if only one
study reported the outcome and consistency could therefore not
be assessed). The main risk of bias was a lack of reporting of the
cause of incomplete outcome data in many studies. Also, most of
the studies had a short follow-up period with the longest follow-
up time of six months only reported in one study. Therefore more
data regarding long-term visual outcomes are needed to draw con-
clusions about the two surgical techniques.
16Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus phacoemulsification with posterior
chamber intraocular lens for age-related cataract (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Potential biases in the review process
We did not identify any obvious biases in the review process, al-
though we did not have enough included studies (10 or more) to
assess publication bias.
Agreements and disagreements with other
studies or reviews
This review agrees with a recently published meta-analysis of six
RCTs (Zhang 2013). Phacoemulsification was associated with im-
proved uncorrected visual acuity compared to MSCIS, but both
procedures resulted in similar best-corrected visual acuity.
A study comparing the cost of the two procedures (Muralikrishnan
2004) found MSICS to cost on average USD 17.03 per case,
whereas phacoemulsification cost USD 25.55 per case. This study
supports the finding thatMSICS is less costly; however, their anal-
yses included costs such as equipment, utilities, labour and mate-
rials in a very high volume setting, so the conclusions drawn are
not directly comparable to the Ruit 2007 study.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
On the basis of eight RCTs included in this review the only sig-
nificant difference found was in UCVA at three months which
favoured phacoemulsification, but there were no differences in
BCVA at three months or in either outcome at six months. There
was no difference found in poor visual outcomes and complica-
tions between these two techniques for cataract surgery. However,
due to a lack of available data the review is currently underpow-
ered to detect differences for rarer complications. The major ad-
vantage of MSICS over phacoemulsification was the lower cost of
this technique .
Implications for research
To be able to draw more comprehensive conclusions, more studies
comparing MSICS and phacoemulsification are required. These
need to have standardised reporting of outcomes enabling data
from different studies to be pooled. In the absence of a formal core
outcome set for such trials, we suggest that the primary outcomes
we have included in this review (presenting visual acuity 6/12 or
better and best corrected visual acuity worse than 6/60) should be
reported as aminimum.However, as this review suggests that there
may not be big differences in terms of visual outcome between
these two interventions, future trials should collect information
on vision-related quality of life and cost utility. Most of the trials
included in this review had a relatively short follow-up period. We
recommend a longer follow-up period ideally 12 months or more.
We recognise that thismay be difficult in some populations but it is
important especially with regard to complications such as posterior
capsule opacification which may become visually significant over
a longer time course.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Cook 2012
Methods Parallel group randomised controlled trial
200 participants (200 eyes) randomised
Follow-up: eight weeks
Participants Age-related cataract in participants over 50 years
Exclusion criteria:
1. People with early cataract (visual acuity better than 6/36)
2. People with coexistent glaucoma
3. People with corneal scar
Demographics:
M:F phacoemulsification 39:61; MSICS 33:67
Mean age: phacoemulsification 66.9 years, MSICS 68.8 years
Black, coloured and white participants
Setting:
Groote Schuur Hospital, University of Cape Town, South Africa
Interventions MSICS n = 100; phacoemulsification n = 100
Outcomes 1. UCVA at day 1 and week 8
2. BCVA at week 8
3. Refraction
4. Intraoperative and postoperative complication
Notes Published data only
Date conducted: not reported
Funding sources: “Nil”
Declarations of interest among the primary researchers: “Nil”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomisation to the two arms of the
study was done using opaque sequentially
numbered envelopes. The randomisation
sequence allocation was generated by a re-
search assistant who randomly selected and
numbered sequential envelopes containing
an instruction on the type of surgery to be
done”
Allocation concealment (selection bias) Low risk “The envelopes were kept in the operating
room, and the next numbered envelope was
opened by the surgeon immediately prior
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Cook 2012 (Continued)
to the surgery”
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk “The patients were not informed about the
method of surgery that was used”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “The ophthalmic assistants and nurses who
tested and recorded the post operative vi-
sual acuitieswere alsomasked to the surgery
that was done”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 80 participants in the phacoemulsifica-
tion group, 85 participants in the MSICS
group completed 8-week follow-up. “Eigh-
teen per cent of our patients were lost to fol-
low-up at eight weeks. Our patients are in-
digent people living both within the Cape
Town Metropole and in more distant rural
areas, and this loss to follow-up is difficult
to control”
Selective reporting (reporting bias) Low risk None obvious.
George 2005
Methods Parallel group randomised controlled trial
124 participants (124 eyes) randomised by computer-generated random numbers
Follow-up: six weeks
Participants Primary diagnosis of nuclear sclerosis grade III or less
Exclusion criteria:
1. Persons with other potential causes of decreased vision
2. Non-age-related cataracts
3. Cataract associated with glaucoma or retinal pathology
4. Phacodenesis
Demographics:
GenderM:F ratio 24:29 forMSICS, 27:33 for phacoemulsification groups.Mean age 58.
75 years for MSICs and 59.63 for phacoemulsification groups (no significant difference
in the age or gender of all three groups)
Study setting:
Community ophthalmic care centre of a tertiary care eye hospital, Tamil Nadu, India
Interventions MSICS n = 62; phacoemulsification n = 62 (ECCE group n = 62, not included in this
review)
Outcomes 1. Mean endothelial cell loss
2. Cell density recorded as no of cells per square millimetre and as a percentage
reduction
3. Mean surgically induced astigmatism (dioptres)
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George 2005 (Continued)
4. Mean prescribed cylindrical correction (dioptres)
5. Postoperative BCVA < 6/18
Participants were reviewed preoperatively, at one day, one week and six weeks postopera-
tively.Only results from the preoperative and six weeks postoperative visits were reported
At six weeks all participants had visual acuity measured, refraction, slit lamp examina-
tion, keratometry, applanation tonometry, specular microscopy and dilated fundus ex-
amination
The six-week follow-up was completed on 52/62 cases in the ECCE group, 53/62 cases
in the MSICS group and 60/62 cases in the phacoemulsification group
No subgroup analyses were performed.
Notes Published data only
Date conducted: not reported
Funding sources: none specified
Declarations of interest among the primary researchers: not mentioned
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Cases were randomized into three groups
based on computer-generated random
numbers. Randomization was carried out
at the time of admission and used the hos-
pital numbers (which were allotted at the
time of the first hospital visit) for allocation
into different groups”. (Page 294)
“Cases were separately randomized for each
surgeon so that equal numbers of each tech-
nique were performed by each surgeon”.
(Page 294)
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Study does not document whether partic-
ipants were aware/ informed of which in-
tervention they were assigned to
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk “Independent observers performed refrac-
tion and keratometry in order to minimize
bias”. (Page 295)
Nomention of masking of outcome assess-
ment
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk The six-week follow-up was completed by
53/62 cases of MSICS and 60/62 cases of
phacoemulsification
The reasons for attrition were not stated
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George 2005 (Continued)
Selective reporting (reporting bias) Unclear risk Primary outcomes implicit but neither out-
comes or protocol clearly stated
Ghosh 2010
Methods Parallel group randomised controlled trial
224 participants (224 eyes) randomised. “In each patient, the eye with more advanced
cataract was included as study eye” (Page 103)
Follow-up: six months
Participants Inclusion criteria:
Age 50 - 75 with age-related cataract
Exclusion criteria:
Fasting plasma glucose more than 126 mg/dl
Any treatment history of diabetes
History of previous eye surgery
Present or past history of uveitis
Ocular disease other than cataract
History of significant eye trauma
Axial length more than 26.5 mm
People with 3+ or more flare (Standardization of Uveitis Nomenclature Working Group)
on the 1st postoperative day were also excluded from study
Demographics:
Mean age: 62 +/- 6 SD years MSICS group; 61 +/- 6 SD Phacoemulsification group
Males: 125 participants (55.8%)
Study setting:
Tertiary care hospital, Kolkata, West Bengal, India
Interventions MSICS n = 112; phacoemulsification n = 112
Outcomes 1. BCVA
2. Mean macular thickness
Notes Published data only
Date conducted: April 2007 to April 2008
Funding sources: none specified
Declarations of interest among the primary researchers: not mentioned
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Each patient was allocated to either
MSICS or phacoemulsification group by
drawing ballots from a sealed envelope”.
(Page 103)
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Ghosh 2010 (Continued)
Allocation concealment (selection bias) Low risk “Allocation to each surgeon was also per-
formed during drawing of ballots, the
two procedures being equally distributed
among two surgeons (PNB, SG)”. (Page
103)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk “The participating surgeons were not in-
volved with the allocation procedure and
were masked concerning the method of
surgery until the patients were prepared
on the table. The patients were masked to
the allocation code until surgery was per-
formed”. (Page 103)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Details not stated in paper
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk “All patients completed the 1st-day and
the 7th-day follow-up. In phacoemulsifica-
tion group, 97 patients came for the 42nd-
day follow-up and 94 patients completed
the 180th-day follow-up. InMSICS group,
100 patients completed the 42nd-day fol-
low-up and 99 came for the 180th-day fol-
low-up”. (Page 103)
Reason for attrition not stated.
Selective reporting (reporting bias) High risk “Five patients in MSICS group (corneal
oedema 1, iridodialysis 1, posterior capsu-
lar rupture 1, sulcus fixation IOL 1, 3+
flare 1) and nine patients in phacoemulsifi-
cation group (corneal oedema 4, posterior
capsular rupture 4, 3+ flare 1) were further
excluded from the study because of vari-
ous preoperative and postoperative compli-
cations necessitating alteration in manage-
ment protocol”. (Page 103)
“Themacular thickness of the five cases that
were excluded for corneal oedema was eval-
uated on the 42nd and the 180th day af-
ter clearance of oedema.When these values
along with the values of two patients with
3+ flare and five patients with capsular rup-
ture were included in the analysis, the dif-
ference in CSMT between the two groups
was still statistically significant”. (Page 104)
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Gogate 2005a
Methods Parallel group randomised controlled trial
400 participants (400 eyes) randomised
Follow-up: six weeks
Participants Primary diagnosis: age-related cataract
Inclusion criteria:
Resident in region, willing and able to attend regular follow-up for one year
Exclusion criteria:
Combined surgical procedure
Other causes of compromised vision (e.g. amblyopia, glaucoma, diabetic retinopathy,
age-related macular degeneration)
Axial length > 26.5 mm
Age < 40 or > 90
Age/mobility would hinder follow-up
Could not give informed consent
Demographics: age 40 - 90, average age 68.1 phacoemulsification, and 60.7 for MSICs
Study setting:
HV Desai Eye hospital, Pune, India
Interventions MSICS n = 201; phacoemulsification n = 199
Outcomes Relevant outcomes:
1. VA at one week and six weeks
2. Intraoperative and postoperative complications
3. Final astigmatism at six weeks postoperative
Adverse events: two phacoemulsification converted to MSICs
Intervals of outcomes: one and six weeks
Number of participants included in analysis:
Phacoemulsification at one week follow-up = 192, at six weeks follow-up = 185
MSICs at one week follow-up = 191, at six weeks follow-up = 187
Notes Published data only
Date conducted: July 2002 to December 2003.
Funding sources: HV Desai hospital and Lakhani Trust
Declarations of interest among the primary researchers: not mentioned
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Allocation of participants: ”Each patient
was randomly allocated to 1 of the 2 groups
by drawing ballots (from sealed envelopes)
at the beginning of surgery, after the patient
was placed on the operating table“. (Page
870)
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Gogate 2005a (Continued)
Allocation concealment (selection bias) Low risk The allocation codes were sealed in se-
quentially numbered opaque envelopes and
placed in the care of the trial manager. The
participating surgeons were not involved in
the care of or the opening of the envelopes
and were informed of the treatment assign-
ment in the operating room immediately
before surgery. The trial statistician who
generated the allocation schedule inHyder-
abad was not involved in the execution of
the assignment. The trial manager opened
the envelope in Pune and was not involved
in the generation of the allocation sched-
ule.” (Page 870)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk “The patients were masked before, during,
and after (during the follow-up) the surgi-
cal intervention regarding the surgical tech-
nique. The patients and the ophthalmol-
ogists in charge of the follow-up outcome
assessment were masked to the treatment
allocation code.”. (Page 870)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk “The patients and the ophthalmologists in
charge of the follow-up outcome assess-
ment were masked to the treatment alloca-
tion code. However, the ophthalmologist
examining the patient on follow-up would
be able to determine the type of surgery”.
(Page 870)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No reasons for attrition were reported.
185/199 completed follow-up in the pha-
coemulsification group and 187/201 com-
pleted follow-up in the MSICs group
Selective reporting (reporting bias) Unclear risk None obvious.
Gogate 2010
Methods Parallel group randomised controlled trial
200 participants randomised: it is most likely that one eye per person was enrolled in
the trial; it was unclear how this eye may have been selected
Follow-up: six weeks
Participants Primary diagnosis: age-related cataract
Inclusion criteria:
Mature cataract
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Gogate 2010 (Continued)
Cataract up to grade 4 hardness
Exclusion criteria:
Ocular comorbidity e.g. acute infection, severe inflammation, pre-existing corneal opac-
ity, black cataract, non-age-related or complicated cataract, glaucoma, pseudoexfoliation,
retinal pathology
Pre-operative endothelial cell count < 2000 cells/mm2
Unable to consent
Demographics:
Gender 47.5% male, mean age 63.7 years for phacoemulsification and 62.7 for MSICs
Study setting:
Tertiary care centre, India
Interventions MSICS n = 100; phacoemulsification n = 100
Outcomes 1. Endothelial cell count - Preoperatively, one week, and six weeks postoperatively
2. Difference in ECCE over time
3. Corrected distance VA at one and six weeks
4. Intra- and postoperative complications up to six weeks
5. Postoperative astigmatism
Number of participants included in the analysis:
at one week, phacoemulsification 92/100, MSICs 94/100.
at six weeks phacoemulsification 71/100, MSICs 75/100
Adverse events were reported for both groups
Notes Published data only
Date conducted: not reported
Funding sources: none specified
Declarations of interest among the primary researchers: “no author has a financial or
proprietary interest in any material or method mentioned”
No correspondence with authors
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Ballots drawn from sealed envelopes at be-
ginning of surgery used to randomly allo-
cate each patient to phacoemulsification or
SICS. There were 50 ballots for each of 4
surgeons; 25 ballots were for SICS and 25
for phacoemulsification. The randomiza-
tion (allocation) schedule for each surgeon
was generated using the EpiTable applica-
tion (Epi Info, Centers for disease control)
at the International Centre for Advance-
ment and Rural Eye Care, L.V. Prasad Eye
Institute, Hyderabad, India.” (Page 248)
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Gogate 2010 (Continued)
Allocation concealment (selection bias) Low risk “The allocation codes were sealed in se-
quentially numbered, opaque envelopes
and kept by the study coordinator. The
envelopes were opened 10 minutes before
surgery. The participating surgeons were
not involved in the care or opening the en-
velopes. If the surgeons performed a dif-
ferent technique or converted from pha-
coemulsification to SICS, the patients were
analyzed on an intent to treat basis”. (Page
248)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk “To minimize bias, patients were masked
to the type of surgery”. (Page 248)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk “Health workers interviewing patients were
also unaware of the type of surgery the pa-
tients were to have. Surgeons were masked
to the technique until 10 minutes before
surgery. Optometrists and ophthalmolo-
gists examining the patient postoperatively
were not masked to the type of surgery.
A different set of ophthalmologists per-
formed the postoperative follow-up and re-
fractions”. Page 248
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No explanation is given of why the attrition
rate was relatively high
“However, patients whose data were not
available (lost to follow-up, data lost) did
not differ from those whose datawere avail-
able in preoperative variables (age, sex, pre-
operative acuity, cataract type, operating
surgeon), intraoperative variables (type of
surgery, surgery time, complications), or 1-
week follow-up outcome measures”. (Page
251)
Missing data balanced in numbers across
intervention groups. 71/100 participants
analysed for phacoemulsification group
and 75/100 analysed for MSICs group
Selective reporting (reporting bias) Unclear risk None obvious
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Ruit 2007
Methods Parallel group randomised controlled trial
108 participants randomised: it is most likely that one eye per person was enrolled in
the trial; it was unclear how this eye may have been selected
Follow-up: six months
Participants Primary diagnosis: decreased visual acuity due to cataract
Exclusion criteria:
Other ocular disease
Demographics:
Median age 65.8 years (phacoemulsification) 63.8 years (MSICS)
Study setting:
Outreach microsurgical eye clinic, Nepal
Interventions MSICS n = 54; phacoemulsification n = 54
Outcomes Outcomes:
1. Operation time
2. Surgical complications intraoperatively and postoperatively
3. UCVA and BCVA
4. Astigmatism
5. Central corneal thickness and keratometry
6. Cost of equipment and consumables
Intervals at which outcomes assessed:
Postoperative days one and five, three and six weeks, three and six months
Adverse events were reported for each intervention
Number of participants included in analysis:
100% follow-up for each intervention at day one postoperatively
phacoemulsification 86%; MSICs 85% follow-up at six months
Notes Published data only
Date conducted: May 2005
Funding sources: none specified
Declarations of interest among the primary researchers: “The authors indicate no source
of funding or financial conflict of interest”
No correspondence with investigators
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Patients who were cleared for cataract
surgery were assigned randomly by picking
a ball from a bag that contained one white
ball and one black ball. A white ball as-
signed the patient to phacoemulsification
with a foldable IOL, which was performed
by one of the authors (D.C.), who is a clini-
cal professor at theUniversity of California,
San Francisco. A black ball assigned the pa-
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Ruit 2007 (Continued)
tient to sutureless manual SICS, which was
performed by another author (S.R.), direc-
tor of the Tilganga Eye Center in Nepal.
After each random assignment, the follow-
ing patient was assigned automatically to
the alter- native procedure”. (Page 33)
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Surgeons were not masked since each sur-
geon performed a different technique
Notmentioned if participants weremasked
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “All postoperative visual acuities and re-
fractions were obtained by ophthalmic as-
sistants who were masked to the treatment
group andhadnot been involved in the pre-
operative portion of the study.” (Page 34)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Cause of attrition rate not known:
“Because of the nature of the outreach
cataract screening process and the poor and
remote setting where most patients reside,
we were unable to determine the reasons
that eight patients in the manual SICS
group and six patients in the phacoemul-
sification group were lost to follow-up”.
(Page 35). 48/54 patients analysed for pha-
coemulsification group and 46/54 analysed
for MSICS group
Selective reporting (reporting bias) Unclear risk None obvious
Singh 2009
Methods Parallel group randomised controlled trial
182 participants randomised: it is most likely that one eye per person was enrolled in
the trial; it was unclear how this eye may have been selected
Follow-up: immediate postoperative (before discharge) only
Participants Inclusions criteria:
People with immature senile cataracts (defined as nucleus sclerosis up to 2+, cortical
cataract 2+ and posterior sub-capsular cataract of any grade)
Exclusion criteria:
All other types of cataracts were excluded.
Demographics:
Mean age 58.2 years (phacoemulsification), 58.7 years (MSICS)
Study setting:
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Singh 2009 (Continued)
Biratnagar Eye Hospital, Nepal
Interventions MSICS n = 89; phacoemulsification n = 93
Outcomes 1. Postoperative uncorrected visual acuity on the first postoperative day
2. Surgery-induced astigmatism
3. Intraoperative and postoperative complications
4. Surgical time
Notes Published data only
Date conducted: May 2007 to June 2007
Funding sources: none
Declarations of interest among the primary researchers: “none”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomization was done with the help of
random number tables”. (Page 96)
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not reported
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “However, the visual acuity recording per-
son was not aware of the study and mask-
ing could be achieved”. (Page 96)
Incomplete outcome data (attrition bias)
All outcomes
Low risk There is no indication in the paper that any
participant did not complete the follow-up
period (one day)
Selective reporting (reporting bias) Low risk None obvious
Venkatesh 2010
Methods Parallel group randomised controlled trial
270 participants randomised: it is most likely that one eye per person was enrolled in
the trial; it was unclear how this eye may have been selected
Follow-up: six weeks
Participants Inclusion criteria:
Participants between 35 years and 70 years of age with white cataract that obscured
fundus visualisation and whose pupils dilated to at least 5.0 mm
Exclusion criteria:
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Venkatesh 2010 (Continued)
Subluxated cataracts and cataracts clearly caused by trauma
Additional exclusion criteria
Coexisting glaucoma
Corneal pathology
Uveitis
Poor pupil dilation (!5.0 mm)
Other known pathology that could impair visual potential
People that were unable to attend the follow-up visits or give informed consent
Demographics:
M:F phacoemulsification group 57:76; 51:86 MSICS group
Mean age: 56 +/- 9.3 years phacoemulsification group; 56.6 +/- 9.5 years MSICS group
Setting:
Aravind Eye Hospital, Pondicherry, India
Interventions MSICS n = 137; phacoemulsification n = 133
Outcomes 1. Rate of intraoperative and postoperative complications
2. BCVA
3. Corneal astigmatism 6 weeks postoperatively
4. Surgical time
Notes Published data only
Date conducted: September 2007 to April 2008
Funding sources: none specified
Declarations of interest among the primary researchers: “no author has a financial or
proprietary interest in any material or method mentioned”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The randomization (allocation) sched-
ule was generated by a DOS-based soft-
ware program at Lions Aravind Institute
for Community Ophthalmology”. (Page
1850)
Allocation concealment (selection bias) Low risk “The allocation codes were sealed in
opaque numbered envelopes that were
opened by the operating room staff ”. (Page
1850)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk “Patients were not informed about the
method of surgery to which they were as-
signed”. (Page 1850)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “The evaluating independent investigator
(an ophthalmologist who was not a study
surgeon) and the examining refractionist
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Venkatesh 2010 (Continued)
whoassessed uncorrected (UDVA) and cor-
rected (CDVA)distance visual acuitieswere
also masked to the identity of the operating
surgeon and the method of surgery”. (Page
1850)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk “Two hundred thirty of 270 patients (85.
2%) completed the 6-week follow-up”.
(Page 1851).
No explanation given for attrition rate
Selective reporting (reporting bias) Low risk None obvious
BCVA: best-corrected visual acuity
ECCE: extracapsular extraction
MSICS: manual small incision cataract surgery
UCVA: uncorrected visual acuity
VA: visual acuity
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Cai 2008 Participants were not randomised to interventions
Centurion 1999 All participants underwent phacoemulsification
Centurion 2005 Retrospective study
Chanis 1993 No direct comparison
Elkady 2009 The study reported on microincision cataract surgery (MICS) versus microcoaxial phacoemulsification
Goel 2012 Cataract surgery with implantation of endocapsular supporting devices
Parmar 2006 This was a study of per-operative contamination of the anterior chamber
Reddy 2007 Non-standard interventions were used
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D A T A A N D A N A L Y S E S
Comparison 1. MSICS versus phacoemulsification
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Good functional vision at 3
months (uncorrected acuity)
3 767 Risk Ratio (M-H, Random, 95% CI) 0.90 [0.84, 0.96]
2 Good functional vision at 12
months (uncorrected acuity)
Other data No numeric data
3 Good functional vision at 3
months (best-corrected acuity)
6 1223 Risk Ratio (M-H, Random, 95% CI) 0.99 [0.98, 1.01]
4 Good functional vision at 12
months (best-corrected acuity)
Other data No numeric data
5 Poor visual outcome at 3 months
(best-corrected acuity worse
than 6/60)
6 1223 Peto Odds Ratio (Peto, Fixed, 95% CI) 2.48 [0.74, 8.28]
6 Poor visual outcome at 12
months (best-corrected acuity
worse than 6/60)
Other data No numeric data
7 Posterior capsular rupture 8 1708 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.07 [0.63, 1.83]
8 Iridodialysis 5 1114 Peto Odds Ratio (Peto, Fixed, 95% CI) 2.37 [0.54, 10.45]
9 Capsulorhesis extended 3 708 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.26 [0.05, 1.30]
10 Postoperative inflammation 3 732 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.19 [0.36, 3.93]
11 Corneal oedema postoperatively 6 1476 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.58 [0.41, 0.83]
12 Corneal oedema 3 to 6 weeks 4 Peto Odds Ratio (Peto, Fixed, 95% CI) Totals not selected
13 Posterior capsule opacification 2 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
14 Endothelial cell loss 2 Mean Difference (IV, Fixed, 95% CI) Totals not selected
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Analysis 1.1. Comparison 1 MSICS versus phacoemulsification, Outcome 1 Good functional vision at 3
months (uncorrected acuity).
Review: Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus phacoemulsification with posterior chamber intraocular lens for
age-related cataract
Comparison: 1 MSICS versus phacoemulsification
Outcome: 1 Good functional vision at 3 months (uncorrected acuity)
Study or subgroup MSICS Phacoemulsification Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Cook 2012 (1) 63/85 69/80 21.1 % 0.86 [ 0.74, 1.00 ]
Gogate 2005a (2) 133/187 150/185 37.6 % 0.88 [ 0.78, 0.98 ]
Venkatesh 2010 (3) 96/117 99/113 41.3 % 0.94 [ 0.84, 1.04 ]
Total (95% CI) 389 378 100.0 % 0.90 [ 0.84, 0.96 ]
Total events: 292 (MSICS), 318 (Phacoemulsification)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.07, df = 2 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 3.02 (P = 0.0026)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours phaco Favours MSICS
(1) 6/18 or better, 8 weeks follow-up
(2) 6/18 or better, 6 weeks follow-up
(3) 6/18 or better, 6 weeks follow-up
Analysis 1.2. Comparison 1 MSICS versus phacoemulsification, Outcome 2 Good functional vision at 12
months (uncorrected acuity).
Good functional vision at 12 months (uncorrected acuity)
Study
Ruit 2007 At 6 months: MSICS: 41/46 Phacoemulsification: 40/48 Risk ratio: 1.07 (95% CI 0.91 to 1.26)
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Analysis 1.3. Comparison 1 MSICS versus phacoemulsification, Outcome 3 Good functional vision at 3
months (best-corrected acuity).
Review: Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus phacoemulsification with posterior chamber intraocular lens for
age-related cataract
Comparison: 1 MSICS versus phacoemulsification
Outcome: 3 Good functional vision at 3 months (best-corrected acuity)
Study or subgroup MSICS Phacoemulsification Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Cook 2012 (1) 73/85 75/80 2.1 % 0.92 [ 0.83, 1.02 ]
George 2005 (2) 52/53 60/60 8.1 % 0.98 [ 0.93, 1.03 ]
Ghosh 2010 (3) 100/100 97/97 35.8 % 1.00 [ 0.98, 1.02 ]
Gogate 2005a (4) 184/187 182/185 24.6 % 1.00 [ 0.97, 1.03 ]
Gogate 2010 (5) 73/75 70/71 9.3 % 0.99 [ 0.94, 1.03 ]
Venkatesh 2010 (6) 115/117 112/113 20.2 % 0.99 [ 0.96, 1.02 ]
Total (95% CI) 617 606 100.0 % 0.99 [ 0.98, 1.01 ]
Total events: 597 (MSICS), 596 (Phacoemulsification)
Heterogeneity: Tau2 = 0.00; Chi2 = 6.06, df = 5 (P = 0.30); I2 =17%
Test for overall effect: Z = 0.82 (P = 0.41)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours phaco Favours MSICS
(1) 6/18 or better, 8 weeks follow-up
(2) better than 6/18, 6 weeks follow-up
(3) 6/12 or better, 6 weeks follow-up
(4) 6/18 or better, 6 weeks follow-up
(5) 6/18 or better, 6 weeks follow-up
(6) 6/18 or better, 6 weeks follow-up
Analysis 1.4. Comparison 1 MSICS versus phacoemulsification, Outcome 4 Good functional vision at 12
months (best-corrected acuity).
Good functional vision at 12 months (best-corrected acuity)
Study
Ruit 2007 At 6 months: MSICS: 45/46 Phacoemulsification: 47/48 Risk ratio: 1.0 (95% CI 0.94 to 1.06)
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Analysis 1.5. Comparison 1 MSICS versus phacoemulsification, Outcome 5 Poor visual outcome at 3
months (best-corrected acuity worse than 6/60).
Review: Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus phacoemulsification with posterior chamber intraocular lens for
age-related cataract
Comparison: 1 MSICS versus phacoemulsification
Outcome: 5 Poor visual outcome at 3 months (best-corrected acuity worse than 6/60)
Study or subgroup MSICS Phacoemulsification
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Cook 2012 (1) 7/85 2/80 81.1 % 3.02 [ 0.79, 11.54 ]
George 2005 (2) 1/53 0/60 9.4 % 8.43 [ 0.17, 428.18 ]
Ghosh 2010 (3) 0/100 0/97 Not estimable
Gogate 2005a (4) 0/187 1/185 9.5 % 0.13 [ 0.00, 6.75 ]
Gogate 2010 (5) 0/75 0/71 Not estimable
Venkatesh 2010 (6) 0/117 0/113 Not estimable
Total (95% CI) 617 606 100.0 % 2.48 [ 0.74, 8.28 ]
Total events: 8 (MSICS), 3 (Phacoemulsification)
Heterogeneity: Chi2 = 2.59, df = 2 (P = 0.27); I2 =23%
Test for overall effect: Z = 1.47 (P = 0.14)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours MSICS Favours phacoe
(1) worse than 6/60, 8 weeks follow-up
(2) worse than 6/18, 6 weeks follow-up
(3) all patients achieved BCVA 6/12 or better, 6 weeks follow-up
(4) worse than 6/60, 6 weeks follow-up
(5) worse than 6/60, 6 weeks follow-up
(6) Follow-up: 6 weeks
Analysis 1.6. Comparison 1 MSICS versus phacoemulsification, Outcome 6 Poor visual outcome at 12
months (best-corrected acuity worse than 6/60).
Poor visual outcome at 12 months (best-corrected acuity worse than 6/60)
Study
Ruit 2007 At six months: BCVA < 6/18 1.9% participants in both groups
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Analysis 1.7. Comparison 1 MSICS versus phacoemulsification, Outcome 7 Posterior capsular rupture.
Review: Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus phacoemulsification with posterior chamber intraocular lens for
age-related cataract
Comparison: 1 MSICS versus phacoemulsification
Outcome: 7 Posterior capsular rupture
Study or subgroup MSICS Phacoemulsification
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Cook 2012 10/100 4/100 24.4 % 2.50 [ 0.85, 7.39 ]
George 2005 0/62 0/62 Not estimable
Ghosh 2010 1/112 4/112 9.2 % 0.29 [ 0.05, 1.73 ]
Gogate 2005a 12/201 7/199 33.8 % 1.72 [ 0.68, 4.31 ]
Gogate 2010 4/100 6/100 17.8 % 0.66 [ 0.18, 2.34 ]
Ruit 2007 0/54 1/54 1.9 % 0.14 [ 0.00, 6.82 ]
Singh 2009 0/89 2/93 3.7 % 0.14 [ 0.01, 2.25 ]
Venkatesh 2010 2/137 3/133 9.2 % 0.65 [ 0.11, 3.78 ]
Total (95% CI) 855 853 100.0 % 1.07 [ 0.63, 1.83 ]
Total events: 29 (MSICS), 27 (Phacoemulsification)
Heterogeneity: Chi2 = 9.42, df = 6 (P = 0.15); I2 =36%
Test for overall effect: Z = 0.26 (P = 0.80)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours MSICS Favours phaco
38Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus phacoemulsification with posterior
chamber intraocular lens for age-related cataract (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.8. Comparison 1 MSICS versus phacoemulsification, Outcome 8 Iridodialysis.
Review: Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus phacoemulsification with posterior chamber intraocular lens for
age-related cataract
Comparison: 1 MSICS versus phacoemulsification
Outcome: 8 Iridodialysis
Study or subgroup MSICS Phaco
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Ghosh 2010 1/112 0/112 14.3 % 7.39 [ 0.15, 372.38 ]
Gogate 2005a 2/201 2/199 57.0 % 0.99 [ 0.14, 7.08 ]
Gogate 2010 1/100 0/100 14.3 % 7.39 [ 0.15, 372.38 ]
Ruit 2007 0/54 0/54 Not estimable
Singh 2009 1/89 0/93 14.3 % 7.73 [ 0.15, 389.87 ]
Total (95% CI) 556 558 100.0 % 2.37 [ 0.54, 10.45 ]
Total events: 5 (MSICS), 2 (Phaco)
Heterogeneity: Chi2 = 1.75, df = 3 (P = 0.63); I2 =0.0%
Test for overall effect: Z = 1.14 (P = 0.26)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours MSICS Favours phaco
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Analysis 1.9. Comparison 1 MSICS versus phacoemulsification, Outcome 9 Capsulorhesis extended.
Review: Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus phacoemulsification with posterior chamber intraocular lens for
age-related cataract
Comparison: 1 MSICS versus phacoemulsification
Outcome: 9 Capsulorhesis extended
Study or subgroup MSICS Phaco
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Gogate 2005a 0/201 2/199 33.4 % 0.13 [ 0.01, 2.14 ]
Gogate 2010 1/100 2/100 49.8 % 0.51 [ 0.05, 4.96 ]
Ruit 2007 0/54 1/54 16.8 % 0.14 [ 0.00, 6.82 ]
Total (95% CI) 355 353 100.0 % 0.26 [ 0.05, 1.30 ]
Total events: 1 (MSICS), 5 (Phaco)
Heterogeneity: Chi2 = 0.67, df = 2 (P = 0.72); I2 =0.0%
Test for overall effect: Z = 1.64 (P = 0.10)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours MSICS Favours phaco
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Analysis 1.10. Comparison 1 MSICS versus phacoemulsification, Outcome 10 Postoperative inflammation.
Review: Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus phacoemulsification with posterior chamber intraocular lens for
age-related cataract
Comparison: 1 MSICS versus phacoemulsification
Outcome: 10 Postoperative inflammation
Study or subgroup MSICS Phaco
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Ghosh 2010 1/112 1/112 18.4 % 1.00 [ 0.06, 16.09 ]
Gogate 2005a 5/201 4/199 81.6 % 1.24 [ 0.33, 4.65 ]
Ruit 2007 0/54 0/54 Not estimable
Total (95% CI) 367 365 100.0 % 1.19 [ 0.36, 3.93 ]
Total events: 6 (MSICS), 5 (Phaco)
Heterogeneity: Chi2 = 0.02, df = 1 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 0.29 (P = 0.77)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours MSICS Favours phaco
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Analysis 1.11. Comparison 1 MSICS versus phacoemulsification, Outcome 11 Corneal oedema
postoperatively.
Review: Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus phacoemulsification with posterior chamber intraocular lens for
age-related cataract
Comparison: 1 MSICS versus phacoemulsification
Outcome: 11 Corneal oedema postoperatively
Study or subgroup MSICS Phaco
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Cook 2012 (1) 29/100 35/100 35.2 % 0.76 [ 0.42, 1.37 ]
Ghosh 2010 (2) 1/112 4/112 3.9 % 0.29 [ 0.05, 1.73 ]
Gogate 2005a (3) 9/201 18/199 20.3 % 0.48 [ 0.22, 1.06 ]
Gogate 2010 (4) 7/100 7/100 10.5 % 1.00 [ 0.34, 2.96 ]
Singh 2009 (5) 0/89 4/93 3.2 % 0.14 [ 0.02, 0.99 ]
Venkatesh 2010 (6) 14/137 25/133 26.9 % 0.50 [ 0.25, 0.99 ]
Total (95% CI) 739 737 100.0 % 0.58 [ 0.41, 0.83 ]
Total events: 60 (MSICS), 93 (Phaco)
Heterogeneity: Chi2 = 4.77, df = 5 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 3.01 (P = 0.0026)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours MSICS Favours phaco
(1) Follow-up: first day after surgery, corneal oedema decreasing visual acuity
(2) Follow-up: first day after surgery
(3) Follow-up: first day after surgery
(4) Follow-up: first day after surgery
(5) Follow-up: one week after surgery
(6) Follow-up: first day after surgery, ”significant” corneal oedema
42Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus phacoemulsification with posterior
chamber intraocular lens for age-related cataract (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.12. Comparison 1 MSICS versus phacoemulsification, Outcome 12 Corneal oedema 3 to 6 weeks.
Review: Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus phacoemulsification with posterior chamber intraocular lens for
age-related cataract
Comparison: 1 MSICS versus phacoemulsification
Outcome: 12 Corneal oedema 3 to 6 weeks
Study or subgroup MSICS Phaco
Peto
Odds Ratio
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Gogate 2005a 0/187 0/185 Not estimable
Gogate 2010 0/100 0/100 Not estimable
Ruit 2007 0/54 0/54 Not estimable
Venkatesh 2010 0/117 0/113 Not estimable
0.01 0.1 1 10 100
Favours MSICS Favours phaco
Analysis 1.13. Comparison 1 MSICS versus phacoemulsification, Outcome 13 Posterior capsule
opacification.
Review: Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus phacoemulsification with posterior chamber intraocular lens for
age-related cataract
Comparison: 1 MSICS versus phacoemulsification
Outcome: 13 Posterior capsule opacification
Study or subgroup MSICS Phaco Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gogate 2005a (1) 0/201 0/199 Not estimable
Ruit 2007 (2) 20/46 7/48 2.98 [ 1.39, 6.37 ]
0.01 0.1 1 10 100
Favours MSICS Favours phaco
(1) Follow-up: six weeks
(2) Follow-up: six months
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Analysis 1.14. Comparison 1 MSICS versus phacoemulsification, Outcome 14 Endothelial cell loss.
Review: Manual small incision cataract surgery (MSICS) with posterior chamber intraocular lens versus phacoemulsification with posterior chamber intraocular lens for
age-related cataract
Comparison: 1 MSICS versus phacoemulsification
Outcome: 14 Endothelial cell loss
Study or subgroup MSICS Phaco
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
George 2005 (1) 53 4.21 (10.29) 60 5.41 (10.99) -1.20 [ -5.13, 2.73 ]
Gogate 2010 (2) 75 17.7 (10) 71 18.4 (10) -0.70 [ -3.95, 2.55 ]
-100 -50 0 50 100
Favours MSICS Favours phaco
(1) Percentage reduction over 6 weeks
(2) Percentage mean cell loss, SD estimated
A D D I T I O N A L T A B L E S
Table 1. Outcome reporting matrix
George
2005
Gogate
2005
Gogate
2010
Ruit 2007 Singh 2009 Cook 2012 Venkatesh
2011
Ghosh
2010
Review out-
comes
Presenting
VA ≥ 6/12
H H I H
BCVA < 6/
60
F F I
Capsular
rupture with
or without
vitreous loss
Iris prolapse H H H H H H H
Postoper-
ative inflam-
mation
H H H H
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Table 1. Outcome reporting matrix (Continued)
Posterior
cap-
sule opacifi-
cation
H H H H H H
Retinal de-
tachment
H H H H H H H H
Glaucoma F H H H H H H H
Cys-
toid macular
oedema
H H H H H H H
Corneal en-
dothelial cell
loss
H H H H H H
Corneal de-
compensa-
tion
H H H H H H H H
Quality of
life
I I I I I I I I
Other out-
comes
(list other
outcomes
reported)
Astigmatism Capsu-
lorhexis ex-
tended, Iri-
dodial-
ysis, zonule
dialysis, De-
scemet tear,
conversion
to MSICS,
Astigmatism
Capsu-
lorhexis ex-
tended,
Conversion
to MSICS,
Iridodialy-
sis, retained
cortex, de-
centred IOL
Capsu-
lorhexis ex-
tended, Mi-
nor
hyphaema,
cost effec-
tiveness,
Astigmatism
Zonule dial-
ysis, surgical
time, Astig-
matism
“Other
complica-
tions”,
corneal
oedema
at day 1, me-
dian
astigmatism
Corneal
oedema at
day 1 and 6
weeks, astig-
matism, sur-
gical time
Macular
thickness
Reported and included in review
F: Clear that outcome was measured but not necessarily analysed. Judgment says unlikely to have been analysed but not reported
because of non-significant results (low risk of bias)
H: Not mentioned but clinical judgment says unlikely to have been measured at all (low risk of bias)
I: Clear that outcome was not measured (no risk)
For other categories see Kirkham 2010
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A P P E N D I C E S
Appendix 1. CENTRAL search strategy
#1 MeSH descriptor Cataract
#2 MeSH descriptor Cataract Extraction
#3 MeSH descriptor Lens, Crystalline
#4 MeSH descriptor Lenses, Intraocular
#5 MeSH descriptor Lens Implantation, Intraocular
#6 intraocular lens* or intra ocular lens* or IOL*
#7 (#1 OR #2 OR #3 OR #4 OR #5 OR #6)
#8 MeSH descriptor Phacoemulsification
#9 pha?oemulsif*
#10 phaco or phako
#11 (#8 OR #9 OR #10)
#12 manual near/3 small near/3 incision near/3 cataract*
#13 MISICS or SICS
#14 MeSH descriptor Capsulorhexis explode all trees
#15 continuous near/3 curvilinear near/3 capsulor*hexis
#16 continuous near/3 circular near/3 capsulor*hexis
#17 CCC or CCS
#18 can opener near/5 capsulotom*
#19 endocapsular
#20 (#12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19)
#21 (#7 AND #11 AND #20)
Appendix 2. MEDLINE (OvidSP) search strategy
1. randomized controlled trial.pt.
2. (randomized or randomised).ab,ti.
3. placebo.ab,ti.
4. dt.fs.
5. randomly.ab,ti.
6. trial.ab,ti.
7. groups.ab,ti.
8. or/1-7
9. exp animals/
10. exp humans/
11. 9 not (9 and 10)
12. 8 not 11
13. exp cataract/
14. cataract extraction/
15. exp lens crystalline/
16. exp lenses intraocular/
17. lens implantation intraocular/
18. (intraocular lens$ or intra ocular lens$ or IOL$).tw.
19. or/13-18
20. phacoemulsification/
21. pha?oemulsif$.tw.
22. (phaco or phako).tw.
23. or/20-22
24. (manual adj3 small adj3 incision adj3 cataract$).tw.
25. (MISICS or SICS).tw.
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26. capsulorhexis/
27. (continuous adj3 curvilinear adj3 capsulorhexis).tw.
28. (continuous adj3 circular adj3 capsulorhexis).tw.
29. (continuous adj3 curvilinear adj3 capsulor?hexis).tw.
30. (CCC or CCS).tw.
31. (can opener adj5 capsulotom$).tw.
32. endocapsular.tw.
33. or/24-32
34. 19 and 23 and 33
35. 12 and 34
The search filter for trials at the beginning of the MEDLINE strategy is from the published paper by Glanville et al (Glanville 2006).
Appendix 3. EMBASE (OvidSP) search strategy
1. exp randomized controlled trial/
2. exp randomization/
3. exp double blind procedure/
4. exp single blind procedure/
5. random$.tw.
6. or/1-5
7. (animal or animal experiment).sh.
8. human.sh.
9. 7 and 8
10. 7 not 9
11. 6 not 10
12. exp clinical trial/
13. (clin$ adj3 trial$).tw.
14. ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$)).tw.
15. exp placebo/
16. placebo$.tw.
17. random$.tw.
18. exp experimental design/
19. exp crossover procedure/
20. exp control group/
21. exp latin square design/
22. or/12-21
23. 22 not 10
24. 23 not 11
25. exp comparative study/
26. exp evaluation/
27. exp prospective study/
28. (control$ or prospectiv$ or volunteer$).tw.
29. or/25-28
30. 29 not 10
31. 30 not (11 or 23)
32. 11 or 24 or 31
33. exp cataract/
34. exp cataract extraction/
35. exp lens/
36. exp lens implant/
37. exp lens implantation/
38. (intraocular lens$ or intra ocular lens$ or IOLS).tw.
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39. or/33-38
40. exp phacoemulsification/
41. pha?oemulsif$.tw.
42. (phaco or phako).tw.
43. or/40-42
44. (manual adj3 small adj3 incision adj3 cataract$).tw.
45. (MISICS or SICS).tw.
46. capsulorhexis/
47. (continuous adj3 curvilinear adj3 capsulorhexis).tw.
48. (continuous adj3 circular adj3 capsulorhexis).tw.
49. (continuous adj3 curvilinear adj3 capsulor?hexis).tw.
50. (CCC or CCS).tw.
51. (can opener adj5 capsulotom$).tw.
52. endocapsular.tw.
53. or/45-52
54. 39 and 43 and 53
55. 32 and 54
Appendix 4. LILACS search strategy
cataract$ and phaco$ or phako$ and manual small incis$ or MISICS or SICS or capsulorhexis or capsulorrhexis
Appendix 5. Web of Science CPCI-S search strategy
#17 #3 and #6 and #16
#16 #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15
#15 TS=can opener capsulotom*
#14 TS=(CCC or CCS)
#13 TS=(continuous circular capsulorrhexis)
#12 TS=(continuous circular capsulorhexis)
#11 TS=(continuous curvilinear capsulorrhexis)
#10 TS=(continuous curvilinear capsulorhexis)
#9 TS=capsulorhexis
#8 TS=(MISICS or SICS)
#7 TS=(manual small incision)
#6 #4 or #5
#5 TS=(phaco or phako)
#4 TS=(phacoemulsification or phakoemulsification)
#3 #1 OR #2
#2 TS=(intraocular lens* or intra ocular lens* or IOL*)
#1 TS=cataract*
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Appendix 6. metaRegister of Controlled Trials search strategy
cataract AND phacoemulsification
Appendix 7. ClinicalTrials.gov search strategy
cataract AND phacoemulsification
Appendix 8. ICTRP search strategy
phacoemulsification = Condition AND manual or MISICS or SICS or capsulorhexis or capsulorrhexis = Intervention
C O N T R I B U T I O N S O F A U T H O R S
Conceiving the review: YR
Designing the review: YR, JE
Co-ordinating the review: YR, JE
Data collection for the review:
- Designing electronic search strategies: Cochrane Eyes and Vision Group editorial base
- Undertaking manual searches:
- Screening search results: YR, JE, SdeS
- Organising retrieval of papers:
- Screening retrieved papers against inclusion criteria: YR, SdeS
- Appraising quality of papers: YR, SdeS, JE
- Extracting data from papers: YR, SdeS, JE
- Writing to authors of papers for additional information: YR
- Providing additional data about papers: SdeS, YR
- Obtaining and screening data on unpublished studies: SdeS, YR
Data management for the review:
- Entering data into Review Manager 5: JE, YR, SdeS
- Checking data entered into Review Manager 5: YR, JE, SdeS
Analysis of data: JE
Interpretation of data:
- Providing a methodological perspective: JE
- Providing a clinical perspective: YR, SdeS
- Providing a policy perspective: YR, SdeS
Writing the review: YR, SdeS, JE
Performing previous work that was the foundation of the current study: YR, JE
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D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
External sources
• Sightsavers, UK.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Primary outcome “presenting visual acuity 6/12 or better”
No study reported presenting visual acuity so we report both uncorrected and best-corrected acuity. Most studies reported 6/18 or
better outcomes and we have used this to indicate ’good functional vision’.
Unit of analysis
The main unit of analysis issue is how the trial investigators dealt with two eyes. There were several options here: a trial may randomise
people to the intervention groups and then apply the intervention and/or measure the outcome in one eye (study eye) or both eyes.
However, if the intervention had been applied to both eyes, it would have been incorrect to analyse eyes without taking into account the
fact that the eyes for a person are not independent. Alternatively a trial may randomly allocate eyes to an intervention so each person
had a different intervention in each eye. In this case, the pairing would have to be taken into account in the analysis. In the protocol
for this review, if the trial had been incorrectly analysed, we planned to contact the trial investigators for further information to enable
calculation of a design effect (Perera 2007). However, in the event this was not necessary.
Assessment of reporting biases
The main reporting biases that we planned to consider were publication bias and outcome reporting bias. Currently there are not
enough trials included in the review to assess publication bias.When there are enough trials (10 or more) we will do a funnel plot to
see if small studies report different effects, one explanation for which could be publication bias
Sensitivity analysis
We planned to do a sensitivity analysis excluding trials at high risk of bias and investigating the impact of missing data. However,
currently there are not enough data to enable this.
’Summary of findings’ tables
This was not specified in the protocol.
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N O T E S
The original published Cochrane review ’Riaz Y, Mehta JS, Wormald R, Evans JR, Foster A, Ravilla T, Snellingen T. Surgical in-
terventions for age-related cataract. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD001323. DOI: 10.1002/
14651858.CD001323.pub2’ has been divided into three smaller reviews each using the same outcome measures as the original review
but only comparing two surgical methods within each review. The interventions being compared are ECCE, MSICS and phacoemulsi-
fication. Intracapsular extraction (ICCE) is no longer included in the reviews as this technique is no longer used as a primary procedure.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Lenses, Intraocular; Age Factors; Cataract Extraction [∗methods]; Lens Implantation, Intraocular [∗methods]; Phacoemulsification
[methods]; Posterior Eye Segment; Randomized Controlled Trials as Topic; Visual Acuity
MeSH check words
Humans
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